سعر جونابيور 75 وحدة دولية/مل امبول للحقن عضل / تحت الجلد 2025

Follitropin alfa 75 IU/mL injection for IM/SC use (Gonapure, Minapharm), 1 ampoule per pack.

• EU: most commonly headache, ovarian cysts and local injection-site reactions; mild or moderate OHSS commonly, severe OHSS uncommon; thromboembolism and hypersensitivity reactions very rarely.General active-ingredient information · European Medicines Agency (EMA)

• EU: hypersensitivity; tumours of the hypothalamus or pituitary gland; ovarian enlargement or cyst of unknown origin unrelated to polycystic ovarian disease; gynaecological haemorrhage of unknown origin; ovarian, uterine or mammary carcinoma; not to be used when an effective response cannot be obtained (primary ovarian failure, malformations of sexual organs or uterine fibroids incompatible with pregnancy, primary testicular insufficiency).General active-ingredient information · European Medicines Agency (EMA)

• EU: risk of ovarian hyperstimulation syndrome (OHSS); monitor ovarian response by ultrasound and/or oestradiol; if excessive response, stop treatment and withhold hCG.General active-ingredient information · European Medicines Agency (EMA)
• EU: increased incidence of multiple pregnancy (mostly twins) and of ectopic pregnancy in women with tubal disease; thromboembolic events may occur in women with risk factors.General active-ingredient information · European Medicines Agency (EMA)

• EU: there is no indication for use during pregnancy; limited data (fewer than 300 pregnancy outcomes) show no malformative or feto/neonatal toxicity, but a teratogenic effect cannot be excluded.General active-ingredient information · European Medicines Agency (EMA)
• EU: not indicated during breast-feeding.General active-ingredient information · European Medicines Agency (EMA)

• EU: monitor follicle size and number by ultrasound and/or oestrogen secretion during stimulation.General active-ingredient information · European Medicines Agency (EMA)

English text not available for this section.